ADVERTISEMENT

American Society of Clinical Oncology guideline update: choosing biomarkers to guide treatment for early-stage breast cancer

Miriam Davis, PhD   |   Clinical Summary   |   27 April 2022
ADVERTISEMENT

Takeaway

  • The American Society of Clinical Oncology has issued an update to its 2016 guidelines on which biomarkers to use for early-stage breast cancer.
  • 31 recommendations govern the use of genomic biomarkers (e.g., Oncotype DX) or protein (Ki67) biomarkers to shape decisions on endocrine and chemotherapy depending on tumor subtype, menopausal...

          

Topic Challenges

left
right